|
Mutation Information
|
Mutation Site
|
W172* |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
S |
|
Combined Mutation
|
s.W172*+rt.A181T |
|
Genotype/Subtype
|
B;C |
|
Relevant Drug
|
lamivudine (LAM);adefovir (ADV) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
21933446
|
|
Disease
|
Chronic hepatitis B;
Hepatocellular carcinoma
|
|
Published Year
|
2011 |
|
Journal
|
BMC cancer |
|
Title
|
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. |
|
Author
|
Yeh CT,Chen T,Hsu CW,Chen YC,Lai MW,Liang KH,Chen TC |
|
Evidence
|
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistantChronic hepatitis B
|
|
|
HBV Mutation Detail Information